AdaptHealth Narrows FY2025 Sales Guidance from $3.150B-$3.290B to $3.180B-$3.260B vs $3.252B Est

Financial Outlook

The Company is updating previous financial guidance for fiscal year 2025, as follows:

• Net revenue of $3.18 billion to $3.26 billion, from $3.15 billion to $3.29 billion
• Adjusted EBITDA of $642 million to $682 million, from $662 million to $702 million
• Free cash flow of $170 million to $190 million, unchanged